Language: English | Chinese
Fri,Mar,29,2024
Home About Zhongshan News Business CULTURE & EDUCATION Services
HOME > Business >Foreign Trade > Zhongshan Bio-Tech obtains export permission for its COVID-19 detection reagent
Zhongshan Bio-Tech obtains export permission for its COVID-19 detection reagent
Updated: 2020-07-10    Source: Zhongshan Daily Large Medium Small Print

0710-4.jpg

China Chamber of Commerce for Medicines & Health Products Import & Export (CCCMHPIE) updated the "List of Medical Devices and Supplies Companies with Export Certification/Authorization from Other Countries" on July 7. Zhongshan Bio-tech Co Ltd is a COVID-19 reagent export enterprise with the serial number "401".

Zhongshan Bio-tech has developed five new COVID-19 detection products within two categories and applied for seven core patents, of which one invention has been quickly authorized by the National Intellectual Property Administration. With its rapid detection kit, the detection process is reduced to less than 15 minutes and the success rate is over 90%.

Zhongshan Bio-tech is a wholly-owned independent subsidiary of Daan Gene Co Limited. Based in Torch Development Zone for 30 years, it has great advantages in the research and development of infectious disease diagnostic reagents and has been assessed as one of Guangdong's premier Medical Instruments and Technologies Research Centers.

In the fight against SARS in 2003, the company played an active role and was awarded the "Advanced Enterprise in the Fight against SARS" honor.

Zhongshan Bio-tech has also exerted positive effects in domestic epidemic prevention and control against COVID-19 this year. The company's COVID-19 IgM/IgG antibody detection kit (colloidal gold method) officially obtained the EU's CE Local Registration Certificate on May 25.

About Zhongshan News Business Culture Services

Copyright © 2018-2019 Zhongshan Daily Newspaper Group. All rights reserved. Presented by zsnews.cn